Literature DB >> 33658735

Disease severity classification and COVID-19 outcomes, Republic of Korea.

Kyung-Bok Son1, Tae-Jin Lee2, Seung-Sik Hwang2.   

Abstract

PROBLEM: The surge in coronavirus disease 2019 (COVID-19) cases overwhelmed the health system in the Republic of Korea. APPROACH: To help health-care workers prioritize treatment for patients with more severe disease and to decrease the burden on health systems caused by COVID-19, the government established a system to classify disease severity. Health-care staff in city- and provincial-level patient management teams classified the patients into the different categories according to the patients' pulse, systolic blood pressure, respiratory rate, body temperature and level of consciousness. Patients categorized as having moderate, severe and very severe disease were promptly assigned to beds or negative-pressure isolation rooms for hospital treatment, while patients with mild symptoms were monitored in 16 designated facilities across the country. LOCAL
SETTING: The case fatality rate was higher in the city of Daegu and the Gyeongsangbuk-do province (1.6%; 124/7756) than the rest of the country (0.5%; 7/1485). RELEVANT CHANGES: From 25 February to 26 March 2020, the ratio of negative-pressure isolation rooms per COVID-19 patient was below 0.15 in the city of Daegu and the Gyeongsangbuk-do province. In the rest of the country, this ratio decreased from 5.56 to 0.63 during the same period. Before the classification system was in place, eight (15.7%) out of the 51 deaths occurred at home or during transfer from home to health-care institutions. LESSONS LEARNT: Categorizing patients according to their disease severity should be a prioritized measure to ease the burden on health systems and reduce the case fatality rate. (c) World Health Organization (WHO) 2021. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 33658735      PMCID: PMC7924894          DOI: 10.2471/BLT.20.257758

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  2 in total

1.  Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy.

Authors:  Graziano Onder; Giovanni Rezza; Silvio Brusaferro
Journal:  JAMA       Date:  2020-05-12       Impact factor: 56.272

2.  Lessons from a COVID-19 hospital, Republic of Korea.

Authors:  Mhinjine Kim; Ji Yeon Lee; Jae Seok Park; Hyun Ah Kim; Miri Hyun; Young-Sung Suh; Sung Il Nam; Woo Jin Chung; Chi-Heum Cho
Journal:  Bull World Health Organ       Date:  2020-10-06       Impact factor: 9.408

  2 in total
  16 in total

1.  Potential Association between the Use of Anabolic Steroids and COVID-19 Infection.

Authors:  Yusuf S Althobaiti; Mohammed S Alzahrani; Shahad M Alhumayani; Shaima A Assiry; Hadeel F Aljuaid; Majed A Algarni
Journal:  Healthcare (Basel)       Date:  2022-01-20

2.  Effectiveness of Tocilizumab in Patients with Severe or Critical Lung Involvement in COVID-19: A Retrospective Study.

Authors:  Daniel Chober; Bogusz Aksak-Wąs; Katarzyna Bobrek-Lesiakowska; Anna Budny-Finster; Ewa Hołda; Joanna Mieżyńska-Kurtycz; Grzegorz Jamro; Miłosz Parczewski
Journal:  J Clin Med       Date:  2022-04-20       Impact factor: 4.241

3.  In COVID-19, NLRP3 inflammasome genetic variants are associated with critical disease and these effects are partly mediated by the sickness symptom complex: a nomothetic network approach.

Authors:  Michael Maes; Walton Luiz Del Tedesco Junior; Marcell Alysson Batisti Lozovoy; Mayara Tiemi Enokida Mori; Tiago Danelli; Elaine Regina Delicato de Almeida; Alexandre Mestre Tejo; Zuleica Naomi Tano; Edna Maria Vissoci Reiche; Andréa Name Colado Simão
Journal:  Mol Psychiatry       Date:  2022-01-12       Impact factor: 13.437

4.  Factors Associated with Mortality Among Hospitalized Adults with COVID-19 Pneumonia at a Private Tertiary Hospital in Tanzania: A Retrospective Cohort Study.

Authors:  Nadeem Kassam; Eric Aghan; Omar Aziz; Hanifa Mbithe; Kamran Hameed; Reena Shah; Salim Surani; James Orwa; Samina Somji
Journal:  Int J Gen Med       Date:  2021-09-08

5.  Prognostic Role of Malnutrition Diagnosed by Bioelectrical Impedance Vector Analysis in Older Adults Hospitalized with COVID-19 Pneumonia: A Prospective Study.

Authors:  Andrea Da Porto; Carlo Tascini; Maddalena Peghin; Emanuela Sozio; Gianluca Colussi; Viviana Casarsa; Luca Bulfone; Elena Graziano; Chiara De Carlo; Cristiana Catena; Leonardo A Sechi
Journal:  Nutrients       Date:  2021-11-15       Impact factor: 5.717

6.  Workload of Healthcare Workers During the COVID-19 Outbreak in Korea: A Nationwide Survey.

Authors:  Hae Suk Cheong; Ki Tae Kwon; Soyoon Hwang; Shin-Woo Kim; Hyun-Ha Chang; Se Yoon Park; Bongyoung Kim; Shinwon Lee; Jiho Park; Sang Taek Heo; Won Sup Oh; Yeonjae Kim; Kyung-Hwa Park; Chang Kyung Kang; NamHee Oh; Su Jin Lim; Seongcheol Yun; Ji Woong Son
Journal:  J Korean Med Sci       Date:  2022-02-14       Impact factor: 2.153

7.  Association of soluble receptor for advanced glycation end-products (sRAGE) serum on COVID-19 severity: A cross-sectional study.

Authors:  Gusti Noor Ramadany Saputra; Resti Yudhawati; Munawaroh Fitriah
Journal:  Ann Med Surg (Lond)       Date:  2022-01-29

8.  Efficacy and Safety of Sinopharm Vaccine for SARS-CoV-2 and breakthrough infections in Iranian Patients with Hemoglobinopathies: A Preliminary Report.

Authors:  Mehran Karimi; Tahereh Zarei; Sezaneh Haghpanah; Azita Azarkeivan; Maryam Naderi; Sara Matin; Asghar Bazrafshan; Zohreh Zahedi; Afshan Shirkavand; Parisa Pishdad; Vincenzo De Sanctis
Journal:  Mediterr J Hematol Infect Dis       Date:  2022-03-01       Impact factor: 3.122

9.  The impact of COVID-19 on the number of active small primary care businesses by severity of the pandemic: evidence from South Korea.

Authors:  Kyung-Bok Son
Journal:  BMC Prim Care       Date:  2022-04-04

10.  Evaluation of expression of VDR-associated lncRNAs in COVID-19 patients.

Authors:  Mohammad Taheri; Lina Moallemi Rad; Bashdar Mahmud Hussen; Fwad Nicknafs; Arezou Sayad; Soudeh Ghafouri-Fard
Journal:  BMC Infect Dis       Date:  2021-06-19       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.